Pfizer Transthyretin Cardiac Amyloidosis Fellowship

Competitive fellowship program to promote training healthcare professionals to recognize, diagnose, and manage ATTR cardiac amyloidosis and foster research in this field. [Page 1]

Overview

• Grant funding up to $80,000 USD to support one fellow for one year [Page 1, Page 2]
• Supports fellowship programs for Cardiologists or Heart Failure Advanced Practice Providers with strong focus on clinical practice, research, and education [Page 1]
• Funding limited to fellow salary and benefits only - no overhead or indirect costs permitted [Page 2]
• Awarded to institution, not individual fellow [Page 2]
• Expert Review Panel evaluates all proposals through competitive process [Page 4]

Priority Areas

• Clinical training programs in regions with continued workforce challenges [Page 2]
• Independent research including observational studies and outcomes research focused on scientific understanding of disease [Page 2]
• Use of screening tools and their impact on improvement of patient health [Page 2]
• Educational time with interdisciplinary team in case review and relevant didactic training [Page 2]
• Fellowship programs with strong mentoring programs that support diversity, equity, and inclusion [Page 5]

Eligibility & Requirements

• Accredited, US-based academic institution [Page 2]
• Institution must have fellowship program that includes independent research and strong mentoring program [Page 2]
• Clinical training may be included but not required [Page 2]
• Fellow must be U.S. Worker (citizen, permanent resident, refugee, or asylee) or hold appropriate non-immigrant visa authorizing U.S. employment [Page 2]
• Do not include name of potential fellow(s) in application materials [Page 2]
• No aspect of fellowship program can benefit Pfizer's business or a Pfizer asset [Page 2, Page 3]
• Fellow time in clinical setting supported by grant funds must not be billed as patient care [Page 2, Page 3]
• Excluded research: pharmaceutical product studies, basic science/fundamental research (animal model, in-vitro) [Page 2]
• Selected fellow will be named in U.S. Physician Payments Sunshine Act transparency reporting [Page 2]
• Evaluation Criteria: Fellowship goals, objectives, medical needs and population health, patient care experience, program criteria, mentoring, training opportunities, and resources [Page 4]

Timeline

• RFP Release Date: March 12, 2026 [Page 3]
• Submission Deadline: May 6, 2026 (23:59 EST) [Page 3]
• Anticipated Grant Award Notification: June 19, 2026 [Page 1, Page 3]
• Anticipated Project Start Date: September 2026 or later [Page 1, Page 3]
• Anticipated Project End Date: September 2027 or 1 year after start [Page 3]

How to Submit:

• Go to www.cybergrants.com/pfizer/GMGFellowship and sign in (first-time users click "Create your password") [Page 3]
• Click "Start A New Fellowship Application" button [Page 3]
• Complete all required sections of online application [Page 3]
• Upload proposal using required Proposal Template (10-15 pages maximum, single-spaced, 12-point font, 1-inch margins) [Page 3, Page 5]
• For "Competitive Grant?" select "Yes" [Page 3]
• Select Primary Area of Interest: "CVM - ATTR-CM (Transthyretin Amyloid Cardiomyopathy) - FEL" [Page 3]
• Select Competitive Grant Program Name: "2026 RD US Cardiac Amyloidosis Fellowship" [Page 3]
• Proposal must include: Cover page with title/abstract, fellowship goals and objectives, methods including mentoring process, resources and institutional capacity, challenges and mitigation plans, institutional support letters (Division Head/Department Chair and Primary/Secondary mentor), budget with additional funding sources disclosed, anticipated timeline, and any additional relevant information [Page 5]
• Questions regarding RFP should be directed to Grant Officer, Talita Honorato-Rzeszewicz (Talita.honorato-rzeszewicz@pfizer.com) with subject line "2026 RD US Cardiac Amyloidosis Fellowship" [Page 4]
• Technical difficulties: Click "Technical Questions" link in CyberGrants [Page 3]
• Applications submitted after deadline will not be reviewed [Page 3]

Please note: Full RFP is attached in the "More Information" section of this page. Faculty and researchers interested in applying for these opportunities based on technologies developed or disclosed at Vanderbilt must submit their proposals through the CTTC.